ANAVEX LIFE SCIENCES CORP. Proceeds from Notes Payable
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2014-09-30, per its 10-K filed 2014-12-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2014-12-29
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for the quarter ending 2014-09-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for the quarter ending 2014-06-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for fiscal 2013 was $250.00K, a 57.01% decline from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for fiscal 2012 was $581.50K, a 22.47% decline from fiscal 2011.
- ANAVEX LIFE SCIENCES CORP. proceeds from notes payable for fiscal 2011 was $750.00K, a 47.00% decline from fiscal 2010.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 89 month | Proceeds from Notes Payable 92 month | Proceeds from Notes Payable 95 month | Proceeds from Notes Payable 98 month | Proceeds from Notes Payable 101 month | Proceeds from Notes Payable 104 month | Proceeds from Notes Payable 107 month | Proceeds from Notes Payable 110 month | Proceeds from Notes Payable 113 month | Proceeds from Notes Payable 116 month | Proceeds from Notes Payable 119 month | Proceeds from Notes Payable 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $0.00 10-K · filed 2014-12-29 | ||||||||||||
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 4 quarters · filed 2014-12-29 | ||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $0.00 derived: sum of 4 quarters · filed 2014-12-29 | $5.65M 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $0.00 derived: sum of 3 quarters · filed 2014-12-29 | $50.00K derived: sum of 4 quarters · filed 2014-12-29 | $5.65M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $0.00 derived: sum of 2 quarters · filed 2014-12-29 | $50.00K derived: sum of 3 quarters · filed 2014-12-29 | $250.00K 10-K · filed 2014-12-29 | $5.65M 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $50.00K derived: sum of 2 quarters · filed 2014-08-13 | $250.00K 10-Q · filed 2014-08-13 | $500.00K derived: sum of 4 quarters · filed 2014-08-13 | $5.65M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $50.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $250.00K 10-Q/A · filed 2014-05-30 | $500.00K derived: sum of 3 quarters · filed 2014-05-30 | $581.50K derived: sum of 4 quarters · filed 2014-05-30 | $5.65M 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $200.00K 10-Q · filed 2014-02-14 | $450.00K derived: sum of 2 quarters · filed 2014-02-14 | $531.50K derived: sum of 3 quarters · filed 2014-02-14 | $531.50K derived: sum of 4 quarters · filed 2014-02-14 | $5.60M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $331.50K derived: sum of 2 quarters · filed 2013-12-30 | $331.50K derived: sum of 3 quarters · filed 2013-12-30 | $581.50K 10-K · filed 2013-12-30 | $5.40M 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | $81.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $81.50K derived: sum of 2 quarters · filed 2013-08-14 | $331.50K 10-Q · filed 2013-08-14 | $331.50K derived: sum of 4 quarters · filed 2013-08-14 | $5.15M 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $250.00K 10-Q · filed 2013-05-17 | $250.00K derived: sum of 3 quarters · filed 2013-05-17 | $1.00M derived: sum of 4 quarters · filed 2013-05-17 | $5.07M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $250.00K 10-Q · filed 2013-02-14 | $250.00K derived: sum of 2 quarters · filed 2013-02-14 | $1.00M derived: sum of 3 quarters · filed 2013-02-14 | $1.00M derived: sum of 4 quarters · filed 2013-02-14 | $5.07M 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $750.00K derived: sum of 2 quarters · filed 2012-12-31 | $750.00K derived: sum of 3 quarters · filed 2012-12-31 | $750.00K 10-K · filed 2012-12-31 | $4.82M 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $750.00K derived: sum of 2 quarters · filed 2012-08-17 | $750.00K 10-Q · filed 2012-08-17 | $790.00K derived: sum of 4 quarters · filed 2012-08-17 | $4.82M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $0.00 10-Q · filed 2012-05-15 | $40.00K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 | $40.00K derived: sum of 2 quarters · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $1.42M 10-K · filed 2011-12-22 | ||||||||||||||
| 2010-06-30 | $1.38M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |